Article
Doxycycline host-directed therapy in human pulmonary tuberculosis
15 Jun 2021
Abstract excerpt
BACKGROUNDMatrix metalloproteinases (MMPs) are key regulators of tissue destruction in tuberculosis (TB) and may be targets for host-directed therapy. We conducted a phase II double-blind, randomized, controlled trial investigating doxycycline, a licensed broad-spectrum MMP inhibitor, in patients with pulmonary TB.METHODSThirty patients with pulmonary TB were enrolled within 7 days of initiating anti-TB treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
